Standard
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. / Agnandji, Selidji Todagbe; Lell, Bertrand; Fernandes, José Francisco; Abossolo, Béatrice Peggy; Methogo, Barbara Gaelle Nfono Ondo; Kabwende, Anita Lumeka; Adegnika, Ayola Akim; Mordmüller, Benjamin; Issifou, Saadou; Kremsner, Peter Gottfried; Sacarlal, Jahit; Aide, Pedro; Lanaspa, Miguel; Aponte, John J; Machevo, Sonia; Acacio, Sozinho; Bulo, Helder; Sigauque, Betuel; Macete, Eusébio; Alonso, Pedro; Abdulla, Salim; Salim, Nahya; Minja, Rose; Mpina, Maxmillian; Ahmed, Saumu; Ali, Ali Mohammed; Mtoro, Ali Takadir; Hamad, Ali Said; Mutani, Paul; Tanner, Marcel; Tinto, Halidou; D'Alessandro, Umberto; Sorgho, Hermann; Valea, Innocent; Bihoun, Biébo; Guiraud, Issa; Kaboré, Berenger; Sombié, Olivier; Guiguemdé, Robert Tinga; Ouédraogo, Jean Bosco; Hamel, Mary J; Kariuki, Simon; Oneko, Martina; Odero, Chris; Otieno, Kephas; Awino, Norbert; McMorrow, Meredith; Muturi-Kioi, Vincent; Lusingu, John; Theander, Thor G; RTS,S Clinical Trials Partnership.
In:
New England Journal of Medicine, Vol. 367, No. 24, 2012, p. 2284-95.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Agnandji, ST, Lell, B, Fernandes, JF, Abossolo, BP, Methogo, BGNO, Kabwende, AL, Adegnika, AA, Mordmüller, B, Issifou, S, Kremsner, PG, Sacarlal, J, Aide, P, Lanaspa, M, Aponte, JJ, Machevo, S, Acacio, S, Bulo, H, Sigauque, B, Macete, E, Alonso, P, Abdulla, S, Salim, N, Minja, R, Mpina, M, Ahmed, S, Ali, AM, Mtoro, AT, Hamad, AS, Mutani, P, Tanner, M, Tinto, H, D'Alessandro, U, Sorgho, H, Valea, I, Bihoun, B, Guiraud, I, Kaboré, B, Sombié, O, Guiguemdé, RT, Ouédraogo, JB, Hamel, MJ, Kariuki, S, Oneko, M, Odero, C, Otieno, K, Awino, N, McMorrow, M, Muturi-Kioi, V, Lusingu, J
, Theander, TG & RTS,S Clinical Trials Partnership 2012, '
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants',
New England Journal of Medicine, vol. 367, no. 24, pp. 2284-95.
https://doi.org/10.1056/NEJMoa1208394APA
Agnandji, S. T., Lell, B., Fernandes, J. F., Abossolo, B. P., Methogo, B. G. N. O., Kabwende, A. L., Adegnika, A. A., Mordmüller, B., Issifou, S., Kremsner, P. G., Sacarlal, J., Aide, P., Lanaspa, M., Aponte, J. J., Machevo, S., Acacio, S., Bulo, H., Sigauque, B., Macete, E., ... RTS,S Clinical Trials Partnership (2012).
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
New England Journal of Medicine,
367(24), 2284-95.
https://doi.org/10.1056/NEJMoa1208394Vancouver
Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BGNO, Kabwende AL et al.
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
New England Journal of Medicine. 2012;367(24):2284-95.
https://doi.org/10.1056/NEJMoa1208394Author
Agnandji, Selidji Todagbe ; Lell, Bertrand ; Fernandes, José Francisco ; Abossolo, Béatrice Peggy ; Methogo, Barbara Gaelle Nfono Ondo ; Kabwende, Anita Lumeka ; Adegnika, Ayola Akim ; Mordmüller, Benjamin ; Issifou, Saadou ; Kremsner, Peter Gottfried ; Sacarlal, Jahit ; Aide, Pedro ; Lanaspa, Miguel ; Aponte, John J ; Machevo, Sonia ; Acacio, Sozinho ; Bulo, Helder ; Sigauque, Betuel ; Macete, Eusébio ; Alonso, Pedro ; Abdulla, Salim ; Salim, Nahya ; Minja, Rose ; Mpina, Maxmillian ; Ahmed, Saumu ; Ali, Ali Mohammed ; Mtoro, Ali Takadir ; Hamad, Ali Said ; Mutani, Paul ; Tanner, Marcel ; Tinto, Halidou ; D'Alessandro, Umberto ; Sorgho, Hermann ; Valea, Innocent ; Bihoun, Biébo ; Guiraud, Issa ; Kaboré, Berenger ; Sombié, Olivier ; Guiguemdé, Robert Tinga ; Ouédraogo, Jean Bosco ; Hamel, Mary J ; Kariuki, Simon ; Oneko, Martina ; Odero, Chris ; Otieno, Kephas ; Awino, Norbert ; McMorrow, Meredith ; Muturi-Kioi, Vincent ; Lusingu, John ; Theander, Thor G ; RTS,S Clinical Trials Partnership. / A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. In: New England Journal of Medicine. 2012 ; Vol. 367, No. 24. pp. 2284-95.
Bibtex
@article{ced6252208024056b4748dd23a9a47c9,
title = "A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants",
abstract = "The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing phase 3 trial. We studied infants 6 to 12 weeks of age recruited for the same trial.",
author = "Agnandji, {Selidji Todagbe} and Bertrand Lell and Fernandes, {Jos{\'e} Francisco} and Abossolo, {B{\'e}atrice Peggy} and Methogo, {Barbara Gaelle Nfono Ondo} and Kabwende, {Anita Lumeka} and Adegnika, {Ayola Akim} and Benjamin Mordm{\"u}ller and Saadou Issifou and Kremsner, {Peter Gottfried} and Jahit Sacarlal and Pedro Aide and Miguel Lanaspa and Aponte, {John J} and Sonia Machevo and Sozinho Acacio and Helder Bulo and Betuel Sigauque and Eus{\'e}bio Macete and Pedro Alonso and Salim Abdulla and Nahya Salim and Rose Minja and Maxmillian Mpina and Saumu Ahmed and Ali, {Ali Mohammed} and Mtoro, {Ali Takadir} and Hamad, {Ali Said} and Paul Mutani and Marcel Tanner and Halidou Tinto and Umberto D'Alessandro and Hermann Sorgho and Innocent Valea and Bi{\'e}bo Bihoun and Issa Guiraud and Berenger Kabor{\'e} and Olivier Sombi{\'e} and Guiguemd{\'e}, {Robert Tinga} and Ou{\'e}draogo, {Jean Bosco} and Hamel, {Mary J} and Simon Kariuki and Martina Oneko and Chris Odero and Kephas Otieno and Norbert Awino and Meredith McMorrow and Vincent Muturi-Kioi and John Lusingu and Theander, {Thor G} and {RTS,S Clinical Trials Partnership}",
year = "2012",
doi = "10.1056/NEJMoa1208394",
language = "English",
volume = "367",
pages = "2284--95",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "24",
}
RIS
TY - JOUR
T1 - A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants
AU - Agnandji, Selidji Todagbe
AU - Lell, Bertrand
AU - Fernandes, José Francisco
AU - Abossolo, Béatrice Peggy
AU - Methogo, Barbara Gaelle Nfono Ondo
AU - Kabwende, Anita Lumeka
AU - Adegnika, Ayola Akim
AU - Mordmüller, Benjamin
AU - Issifou, Saadou
AU - Kremsner, Peter Gottfried
AU - Sacarlal, Jahit
AU - Aide, Pedro
AU - Lanaspa, Miguel
AU - Aponte, John J
AU - Machevo, Sonia
AU - Acacio, Sozinho
AU - Bulo, Helder
AU - Sigauque, Betuel
AU - Macete, Eusébio
AU - Alonso, Pedro
AU - Abdulla, Salim
AU - Salim, Nahya
AU - Minja, Rose
AU - Mpina, Maxmillian
AU - Ahmed, Saumu
AU - Ali, Ali Mohammed
AU - Mtoro, Ali Takadir
AU - Hamad, Ali Said
AU - Mutani, Paul
AU - Tanner, Marcel
AU - Tinto, Halidou
AU - D'Alessandro, Umberto
AU - Sorgho, Hermann
AU - Valea, Innocent
AU - Bihoun, Biébo
AU - Guiraud, Issa
AU - Kaboré, Berenger
AU - Sombié, Olivier
AU - Guiguemdé, Robert Tinga
AU - Ouédraogo, Jean Bosco
AU - Hamel, Mary J
AU - Kariuki, Simon
AU - Oneko, Martina
AU - Odero, Chris
AU - Otieno, Kephas
AU - Awino, Norbert
AU - McMorrow, Meredith
AU - Muturi-Kioi, Vincent
AU - Lusingu, John
AU - Theander, Thor G
AU - RTS,S Clinical Trials Partnership
PY - 2012
Y1 - 2012
N2 - The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing phase 3 trial. We studied infants 6 to 12 weeks of age recruited for the same trial.
AB - The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing phase 3 trial. We studied infants 6 to 12 weeks of age recruited for the same trial.
U2 - 10.1056/NEJMoa1208394
DO - 10.1056/NEJMoa1208394
M3 - Journal article
C2 - 23136909
VL - 367
SP - 2284
EP - 2295
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 24
ER -
